Book contents
- Clinical Neuroendocrinology
- Clinical Neuroendocrinology
- Copyright page
- Dedication
- Contents
- Preface
- Acknowledgments
- Chapter 1 Basic Principles in Clinical Neuroendocrinology I: Receptor Mechanisms
- Chapter 2 Basic Principles in Clinical Neuroendocrinology II: Assays, Rhythms and Pulses
- Chapter 3 Neuroendocrinology of Female Reproduction
- Chapter 4 Neuroendocrine Regulation of Appetite and Body Weight
- Chapter 5 Hypothalamic–Pituitary–Adrenal Cortex Axis
- Chapter 6 Hypothalamic Regulation of Thyroid Function
- Chapter 7 Hypothalamic Regulation of Prolactin Secretion
- Chapter 8 Regulation of Growth Hormone Secretion
- Chapter 9 Posterior Pituitary
- Chapter 10 An Introduction to Sellar Masses
- Appendix Answers to Review Questions
- Index
- References
Chapter 1 - Basic Principles in Clinical Neuroendocrinology I: Receptor Mechanisms
Published online by Cambridge University Press: 24 December 2018
Book contents
- Clinical Neuroendocrinology
- Clinical Neuroendocrinology
- Copyright page
- Dedication
- Contents
- Preface
- Acknowledgments
- Chapter 1 Basic Principles in Clinical Neuroendocrinology I: Receptor Mechanisms
- Chapter 2 Basic Principles in Clinical Neuroendocrinology II: Assays, Rhythms and Pulses
- Chapter 3 Neuroendocrinology of Female Reproduction
- Chapter 4 Neuroendocrine Regulation of Appetite and Body Weight
- Chapter 5 Hypothalamic–Pituitary–Adrenal Cortex Axis
- Chapter 6 Hypothalamic Regulation of Thyroid Function
- Chapter 7 Hypothalamic Regulation of Prolactin Secretion
- Chapter 8 Regulation of Growth Hormone Secretion
- Chapter 9 Posterior Pituitary
- Chapter 10 An Introduction to Sellar Masses
- Appendix Answers to Review Questions
- Index
- References
- Type
- Chapter
- Information
- Clinical NeuroendocrinologyAn Introduction, pp. 1 - 13Publisher: Cambridge University PressPrint publication year: 2019
References
Barton, M. (2016). Not lost in translation: emerging clinical importance of the G protein-coupled estrogen receptor GPER. Steroids 111, 37–45.Google Scholar
Ben-Shlomo, A & Melmed, S. (2010). Pituitary somatostatin receptor signaling. Trends Endocr Metab 21, 123–133.CrossRefGoogle ScholarPubMed
Bernard, V, Young, J, Chanson, P & Binart, N. (2015). New insights in prolactin: pathological implications. Nat Rev Endocr 11, 265–275.Google Scholar
Brooks, A J & Waters, M J. (2010). The growth hormone receptor: mechanism of activation and clinical implications. Nat Rev Endocr 6, 515–525.Google Scholar
Chaidarun, S S, Swearingen, B & Alexander, JM. (1998). Differential expression of estrogen receptor-β (ERβ) in human pituitary tumors: functional interactions with ERα and a tumor-specific splice variant. J Clin Endocr Metab 83, 3308–3315.Google Scholar
Charmandari, E, Kino, T, Ichijo, T & Chrousos, G P. (2008). Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder. J Clin Endocr Metab 93, 1563–1572.CrossRefGoogle ScholarPubMed
Charmandari, E, Kino, T & Chrousos, G P. (2013). Primary generalized familial and sporadic glucocorticoid resistance (Chrousos syndrome) and hypersensitivity. Endocr Dev 24, 67–85.Google Scholar
Dodington, D W, Desai, H R & Woo, M. (2018). JAK/STAT – Emerging players in metabolism. Trends Endocr Metab 29, 55–65.Google Scholar
Engel, J B & Schally, A V. (2007). Drug insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone. Nat Clin Practice Endocr Metab 3, 157–167.Google Scholar
Farooqi, IS, Wangensteen, T, Collins, S et al. (2007). Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. New Engl J Med 356, 237–247.Google Scholar
Fukami, M, Suzuki, E, Igarashi, M, Miyado, M & Ogata, T. (2018). Gain-of-function mutations in G-protein–coupled receptor genes associated with human endocrine disorders. Clin Endocr 88, 351–359.Google Scholar
Hauser, A S, Attwood, M M, Rask-Andersen, M, Schiöth, H B & Gloriam, D E. (2017). Trends in GPCR drug discovery: new agents, targets and indications. Nat Revs Drug Discovery 16, 829–842.CrossRefGoogle ScholarPubMed
Hiort, O. (2013). Clinical and molecular aspects of androgen insensitivity. Endocr Develop 24, 33–40.Google Scholar
Huang, D, Yang, F, Wang, Y & Guan, X. (2017). Mechanisms of resistance to selective estrogen receptor down-regulator in metastatic breast cancer. Biochim Biophys Acta 1868, 148–156.Google Scholar
Hwa, V. (2016). STAT5B deficiency: impacts on human growth and immunity. Growth Horm IGF Res 28, 16–20.Google Scholar
Jayasena, C N, Nijher, G M K, Chaudhri, O B et al. (2009). Subcutaneous injection of kisspeptin-54 acutely stimulates gonadotropin secretion in women with hypothalamic amenorrhea, but chronic administration causes tachyphylaxis. J Clin Endocr Metab 94, 4315–4323.Google Scholar
Jia, M, Dahlman-Wright, K & Gustafsson, J A. (2015). Estrogen receptor alpha and beta in health and disease. Best Prac Res Clin Endocr Metab 29, 557–568.Google Scholar
Lania, A G, Mantovani, G & Spada, A. (2006). Mechanisms of disease: mutations of G proteins and G-protein-coupled receptors in endocrine diseases. Nat Clin Practice Endocr Metab 2, 681–693.Google Scholar
Manoranjan, B, Salehi, F, Scheithauer, B W, Rotondo, F, Kovacs, K & Cusimano, M D. (2010). Estrogen receptors alpha and beta immunohistochemical expression: clinicopathological correlations in pituitary adenomas. Anticancer Res 30, 2897–2904.Google Scholar
McEwan, I J & Brinkmann, A O. (2016). Androgen physiology: Receptor and metabolic disorders. In: Endocrinology of Male Reproduction; Simoni, M & Huhtaniemi, I T, Eds. Berlin: Springer. www.Endotext.org.Google Scholar
Monteleone, P, Mascagni, G, Giannini, A, Genazzani, A R & Simoncini, T. (2018). Symptoms of menopause – global prevalence, physiology and implications. Nat Rev Endocr 14, 199–215.CrossRefGoogle ScholarPubMed
Myers Jr., M G, Leibel, R L, Seeley, R J & Schwartz, M W. (2010). Obesity and leptin resistance: distinguishing cause from effect. Trends Endocr Metab 21, 643–651.Google Scholar
Neumann, E, Khawaja, K & Müller-Ladner, U. (2014). G protein-coupled receptors in rheumatology. Nat Rev Rheumatol 10, 429–436.Google Scholar
Ortiga-Carvalho, T M, Sidhaye, A R & Wondisford, F E. (2014). Thyroid hormone receptors and resistance to thyroid hormone disorders. Nat Rev Endocr 10, 582–591.Google Scholar
Paterni, I, Granchi, C, Katzenellenbogen, J A & Minutolo, F. (2014). Estrogen receptors alpha (ERα) and beta (ERβ): subtype-selective ligands and clinical potential. Steroids 90, 13–29.Google Scholar
Prossnitz, ER & Barton, M. (2011). The G-protein-coupled estrogen receptor GPER in health and disease. Nat Rev Endocr 7, 715–726.Google Scholar
Rodriguez, J M, Monsalves-Alvarez, M, Henriquez, S, Llanos, M N & Troncoso, R. (2016). Glucocorticoid resistance in chronic diseases. Steroids 115, 182–192.Google Scholar
Rosenfeld, R G, Belgorosky, A, Camacho-Hubner, C, Savage, M O, Wit, J M & Hwa, V. (2007). Defects in growth hormone receptor signaling. Trends Endocr Metab 18, 134–140.Google Scholar
Simmen, R C M & Kelley, A S. (2016). Reversal of fortune: estrogen receptor-beta in endometriosis. J Mol Endocr 57, F23–F27.Google Scholar
Southworth, M B, Matsumoto, A M, Gross, K M, Soules, M R & Bremner, W J. (1991). The importance of signal pattern in the transmission of endocrine information: pituitary gonadotropin responses to continuous and pulsatile gonadotropin-releasing hormone. J Clin Endocr Metab 72, 1286–1289.Google Scholar
Vandewalle, J, Luypaert, A, De Bosscher, K & Libert, C. (2018). Therapeutic mechanisms of glucocorticoids. Trends Endocr Metab 29, 42–54.Google Scholar
Vassart, G & Costagliola, S. (2011). G protein-coupled receptors: mutations and endocrine diseases. Nat Rev Endocr 7, 362–372.Google Scholar
Warner, M, Huang, B & Gustafsson, J-A. (2017). Estrogen receptor β as a pharmaceutical target. Trends Pharmacol Sci 38, 92–99.Google Scholar
Wettschureck, N & and Offermanns, S. (2005). Mammalian G proteins and their cell type specific functions. Physiol Rev 85, 1159–1204.Google Scholar